Net Income (Loss) Attributable to Parent in USD of MediXall Group, Inc. from 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
MediXall Group, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2012 to Q3 2024.
  • MediXall Group, Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2024 was $264K.
  • MediXall Group, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2024 was -$2.16M, a 55.8% increase year-over-year.
  • MediXall Group, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$4.56M, a 33.2% increase from 2022.
  • MediXall Group, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$6.83M, a 10.2% decline from 2021.
  • MediXall Group, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$6.2M, a 4.53% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

MediXall Group, Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$2.16M $264K +$1.17M 01 Jul 2024 30 Sep 2024 10-Q 08 Sep 2025
Q2 2024 -$3.33M -$486K +$494K +50.4% 01 Apr 2024 30 Jun 2024 10-Q 08 Sep 2025
Q1 2024 -$3.83M -$487K +$735K +60.2% 01 Jan 2024 31 Mar 2024 10-Q 08 Sep 2025
Q4 2023 -$4.56M -$1.45M +$328K +18.4% 01 Oct 2023 31 Dec 2023 10-K 27 Jan 2025
Q3 2023 -$4.89M -$908K +$176K +16.2% 01 Jul 2023 30 Sep 2023 10-Q 08 Sep 2025
Q2 2023 -$5.07M -$979K +$575K +37% 01 Apr 2023 30 Jun 2023 10-Q 08 Sep 2025
Q1 2023 -$5.64M -$1.22M +$1.19M +49.3% 01 Jan 2023 31 Mar 2023 10-Q 08 Sep 2025
Q4 2022 -$6.83M -$1.78M +$35.4K +1.95% 01 Oct 2022 31 Dec 2022 10-K 27 Jan 2025
Q3 2022 -$6.87M -$1.08M +$307K +22.1% 01 Jul 2022 30 Sep 2022 10-Q 20 Jun 2024
Q2 2022 -$7.17M -$1.55M +$105K +6.34% 01 Apr 2022 30 Jun 2022 10-Q 20 Jun 2024
Q1 2022 -$7.28M -$2.41M -$1.08M -80.9% 01 Jan 2022 31 Mar 2022 10-Q 20 Jun 2024
Q4 2021 -$6.2M -$1.82M +$150K +7.64% 01 Oct 2021 31 Dec 2021 10-K 09 Aug 2023
Q3 2021 -$6.35M -$1.39M -$425K -43.9% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$5.93M -$1.66M -$513K -44.8% 01 Apr 2021 30 Jun 2021 10-Q 14 Nov 2022
Q1 2021 -$5.41M -$1.33M +$519K +28% 01 Jan 2021 31 Mar 2021 10-Q 14 Nov 2022
Q4 2020 -$5.93M -$1.97M -$677K -52.4% 01 Oct 2020 31 Dec 2020 10-K 19 Apr 2022
Q3 2020 -$5.26M -$967K -$252K -35.2% 01 Jul 2020 30 Sep 2020 10-Q 17 Nov 2021
Q2 2020 -$5M -$1.15M -$476K -71% 01 Apr 2020 30 Jun 2020 10-Q 30 Sep 2021
Q1 2020 -$4.53M -$1.85M -$1.11M -149% 01 Jan 2020 31 Mar 2020 10-Q 03 Aug 2021
Q4 2019 -$3.42M -$1.29M -$671K -108% 01 Oct 2019 31 Dec 2019 10-K 17 Jun 2021
Q3 2019 -$2.75M -$715K +$20.3K +2.76% 01 Jul 2019 30 Sep 2019 10-Q 17 Nov 2020
Q2 2019 -$2.77M -$670K -$54.3K -8.81% 01 Apr 2019 30 Jun 2019 10-Q 17 Nov 2020
Q1 2019 -$2.72M -$744K +$267K +26.4% 01 Jan 2019 31 Mar 2019 10-Q 17 Nov 2020
Q4 2018 -$2.98M -$620K -$172K -38.2% 01 Oct 2018 31 Dec 2018 10-K 14 May 2020
Q3 2018 -$2.81M -$735K -$391K -114% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$2.42M -$616K -$240K -63.8% 01 Apr 2018 30 Jun 2018 10-Q 14 Nov 2019
Q1 2018 -$2.18M -$1.01M -$623K -160% 01 Jan 2018 31 Mar 2018 10-Q 14 Nov 2019
Q4 2017 -$1.56M -$449K -$230K -106% 01 Oct 2017 31 Dec 2017 10-K 16 May 2019
Q3 2017 -$1.33M -$344K -$117K -51.5% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$1.21M -$376K -$224K -148% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 -$986K -$389K -$329K -545% 01 Jan 2017 31 Mar 2017 10-Q 29 Jun 2018
Q4 2016 -$657K -$218K -$196K -889% 01 Oct 2016 31 Dec 2016 10-K 05 Mar 2018
Q3 2016 -$461K -$227K -$98.5K -76.7% 01 Jul 2016 30 Sep 2016 10-Q 20 Nov 2017
Q2 2016 -$362K -$152K -$43.7K -40.5% 01 Apr 2016 30 Jun 2016 10-Q 21 Aug 2017
Q1 2016 -$319K -$60.3K +$29.9K +33.2% 01 Jan 2016 31 Mar 2016 10-Q 22 May 2017
Q4 2015 -$349K -$22.1K +$56.3K +71.8% 01 Oct 2015 31 Dec 2015 10-K 30 Mar 2017
Q3 2015 -$405K -$128K +$29.1K +18.5% 01 Jul 2015 30 Sep 2015 10-Q 04 Nov 2016
Q2 2015 -$434K -$108K +$169K +61.1% 01 Apr 2015 30 Jun 2015 10-Q 12 Aug 2016
Q1 2015 -$603K -$90.2K +$80.8K +47.2% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016
Q4 2014 -$684K -$78.4K 01 Oct 2014 31 Dec 2014 10-Q 04 Nov 2016
Q3 2014 -$158K +$375K +70.4% 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015
Q2 2014 -$277K 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$171K 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015
Q3 2013 -$533K 01 Jul 2013 30 Sep 2013 10-Q 16 Dec 2014

MediXall Group, Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$4.56M +$2.27M +33.2% 01 Jan 2023 31 Dec 2023 10-K 27 Jan 2025
2022 -$6.83M -$630K -10.2% 01 Jan 2022 31 Dec 2022 10-K 27 Jan 2025
2021 -$6.2M -$269K -4.53% 01 Jan 2021 31 Dec 2021 10-K 09 Aug 2023
2020 -$5.93M -$2.51M -73.4% 01 Jan 2020 31 Dec 2020 10-K 19 Apr 2022
2019 -$3.42M -$438K -14.7% 01 Jan 2019 31 Dec 2019 10-K 17 Jun 2021
2018 -$2.98M -$1.43M -91.6% 01 Jan 2018 31 Dec 2018 10-K 14 May 2020
2017 -$1.56M -$900K -137% 01 Jan 2017 31 Dec 2017 10-K 16 May 2019
2016 -$657K -$309K -88.5% 01 Jan 2016 31 Dec 2016 10-K 05 Mar 2018
2015 -$349K +$335K +49% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2017
2014 -$684K +$304K +30.8% 01 Jan 2014 31 Dec 2014 10-Q 04 Nov 2016
2013 -$988K -$836K -551% 01 Jan 2013 31 Dec 2013 10-K 30 Apr 2015
2012 -$152K 01 Jan 2012 31 Dec 2012 10-Q 16 Dec 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.